Merck & Company Inc (MRK) SEC News Oct. 30, 2025, 10:40 UTC (10% Negative) Merck & Co., Inc. (MRK) Reports Q4 2025 Financial Results Full text
Register to leave comments News bot Oct. 30, 2025, 10:42 a.m. 📋 Merck & Co., Inc. (MRK) - Financial Results Filing Date: 2025-10-30 Accepted: 2025-10-30 06:40:38 Event Type: Financial Results Event Details: Merck & Company Inc (MRK) Reports Q4 2025 Financial Results Merck & Company Inc (MRK) announced its financial results for the period ending Q4 2025. Key Financial Highlights: Revenue: 303 Net Income: 15291 EPS: 2.58 Cash and equivalents: Not disclosed expected in the fourth quarter of 2025 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2025 2024 Change ($) Change (%) Costs Expenses And Other Selling General Administrative 7.83K 7.95K $-117.00 -1.47% Costs Expenses And Other Total Other Income Expense 281.00 151.00 $130.00 +86.09% Revenue 50.00 50.00 $0.00 +0.00% Selling, General & Administrative 2.63K 2.63K $0.00 +0.00% Noncontrolling Interests 2.00 2.00 $0.00 +0.00% 💼 Business Developments: PartnershipAcquisitionLicensingRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Merck & Company IncCIK: 0000310158Ticker Symbol: MRKPeriod End Date: 2025-10-30Document Type: 8-K
📋 Merck & Co., Inc. (MRK) - Financial Results
Filing Date: 2025-10-30
Accepted: 2025-10-30 06:40:38
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: